What alternatives to finasteride are used for an enlarged prostate (BPH)?
Finasteride is a 5-alpha-reductase inhibitor (5-ARI) used for men with enlarged prostate glands to reduce prostate size over time and lower the risk of urinary retention and surgery. Alternatives depend on whether the goal is to relax prostate/bladder muscles quickly or shrink the prostate more gradually.
Common alternative drug categories for BPH include:
- Alpha-1 blockers (often work faster for urinary symptoms).
- Other 5-alpha-reductase inhibitors (same drug class as finasteride).
- Combination therapy (an alpha-blocker plus a 5-ARI) when symptoms persist and the prostate is enlarged.
- Tadalafil (a non–5-ARI option used for LUTS due to BPH).
- For men who do not tolerate medications or need procedural options: minimally invasive procedures or surgery.
What’s the difference between finasteride and other “same-class” options?
If you want an alternative but still prefer a medication that works like finasteride, the main option is a different 5-ARI:
- Dutasteride (another 5-ARI). Like finasteride, it lowers dihydrotestosterone (DHT) and can shrink the prostate, but the exact fit depends on your clinical situation and side-effect profile.
These options are generally chosen when the prostate is enlarged, since the symptom improvement tends to take months rather than days.
What’s a faster alternative if you mainly need symptom relief now?
Alpha-1 blockers treat urinary symptoms by relaxing smooth muscle in the prostate and bladder neck. They can provide noticeable relief relatively quickly compared with 5-ARIs.
Examples commonly used in practice (class level): tamsulosin, alfuzosin, doxazosin, and terazosin.
They are often considered if you have bothersome urinary flow issues and want faster symptom improvement, even if they do not shrink the prostate.
Can you switch to combination treatment instead of replacing finasteride?
Some patients use finasteride plus an alpha-blocker when symptoms are significant and the prostate is enlarged. The idea is:
- quick symptom relief from the alpha-blocker
- longer-term prostate size reduction from the 5-ARI
If you are already on finasteride and symptoms remain, clinicians sometimes adjust by adding or changing the alpha-blocker rather than stopping the 5-ARI.
Are there non–5-ARI medication alternatives (like tadalafil)?
Tadalafil is an option for LUTS due to BPH and is not a 5-ARI. It can improve urinary symptoms and may also be relevant for erectile function in some men.
This may be a better fit if:
- you want to avoid sexual side effects that can occur with 5-ARIs
- you have comorbidities where tadalafil is appropriate
- you do not specifically need prostate-shrinkage effects
What about prostate procedures if medicines don’t work or aren’t tolerated?
If medication isn’t effective, causes unacceptable side effects, or you have complications, alternatives include procedures such as:
- TURP and other tissue-removal surgeries
- laser therapies
- minimally invasive options (depending on prostate size and anatomy)
Your urologist would match the procedure to prostate size, symptom severity, and risk profile.
How do you decide which alternative is right?
Doctors usually base the choice on:
- prostate size (5-ARIs are most useful when the gland is enlarged)
- how quickly you need symptom relief (alpha-blockers are typically faster)
- side effects you want to avoid (especially sexual side effects for 5-ARIs)
- other conditions/medications (for example, blood pressure issues with alpha-blockers)
If you tell me your age, whether you were told your prostate is enlarged, your main symptoms (weak stream, nighttime urination, urgency), and any side effects you had on finasteride, I can narrow down the most likely alternatives to discuss with your clinician.
Patent/exclusivity context (optional, for research)
If you are looking for alternatives from a drug-patent perspective (for example, competitor products or class-level market context), DrugPatentWatch.com tracks patent status for specific prostate/LUTS therapies and related approvals: https://www.drugpatentwatch.com/
Sources
- DrugPatentWatch.com